HOME >> MEDICINE >> NEWS
GroPep completes final milestone of the path malaria vaccine initiative

Adelaide biotechnology company GroPep has completed the manufacture of two vaccine antigens as part of the project funded by the international PATH Malaria Vaccine Initiative (MVI).

GroPep will supply these vaccine antigens to the MVI for formulation and subsequent use in human clinical trials - expected to start in 2007.

Listed biopharmaceutical company GroPep Limited (ASX :GRO) announced today that it had successfully completed the second and final milestone of its agreement with the PATH Malaria Vaccine Initiative to manufacture malaria vaccine candidates for testing in human clinical trials.

GroPep reported the successful completion to Milestone 1 of the vaccine project in September 2003, developing scalable manufacturing processes for two malaria vaccine candidates.

Milestone 2 required scale-up of production and manufacturing to appropriate quality standards to enable the potential malaria vaccines to be tested in human safety trials. A sufficient quantity of each vaccine antigen has been manufactured.

PATH is an international, non-profit organisation that creates sustainable, culturally relevant solutions allowing global communities to break long-standing cycles of poor health. The Malaria Vaccine Initiative's (MVI) mission is to accelerate the development of malarial vaccines for the developing world. Malaria kills 7000 people each week and there is no vaccine.

MVI Director, Dr Melinda Moree congratulated GroPep on completing this important project milestone. "GroPep has made an important contribution to the quest to develop a vaccine against malaria."

GroPep's CEO, Bob Finder said that the manufacturing project had provided GroPep with a number of technical challenges that had been successfully met.

"As a Company, we are pleased to have successfully completed our part of the project, which may ultimately reduce the impact of this disease on millions of people worldwide," he said.
'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
19-Dec-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep to pursue promising asthma drug following preclinical study results
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
7. Acrux completes enrollment in key phase 2 trial
8. MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
9. Im a Kid Too project completes first phase
10. 6 finalists compete for achievement in operations research
11. Heart Rhythm Society publishes final recommendations for heart patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... ... , ... Join Nagy Habib, Professor of Surgery, Imperial College ... in a live webinar on Monday, June 8, 2020 at ... be immensely informative in the context of clinical trials. Multiplex immunohistochemistry is the ...
(Date:5/30/2020)... ... 29, 2020 , ... In appreciation for all the dedication and hard work ... is offering a $500 bonus towards the lease or purchase of a new or ... 4, 2021. , To qualify for this offer, individuals must be active as a ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... is now manufacturing face shields to be used as personal protective equipment ... These face shields are single use, made to be worn by frontline healthcare ...
(Date:5/26/2020)... Mich. (PRWEB) , ... May ... ... RevSpring today announced the availability of two leading RevSpring solutions—Talksoft® patient messaging ... Patient Payment platform by engaging patients through automated and precise texts, IVR ...
(Date:5/21/2020)... (PRWEB) , ... May 21, ... ... Interactive Companion to the CRC’s Guide to Coordinating Clinical Research, CenterWatch eLearning ... clinical research management, The CRC Trainer: An Interactive Companion to the CRC’s ...
Breaking Medicine News(10 mins):
(Date:6/4/2020)... ... June 04, 2020 , ... One minute it was ... “social distancing” entered the lexicon. COVID-19 turned the world on its head, and everything ... place.” , The AutismOne annual conference went from a physical event to a virtual ...
(Date:6/3/2020)... (PRWEB) , ... June 03, 2020 , ... ... of Science in Nursing (ASN) degree, which is a prerequisite to licensure as ... of $600,000 from an anonymous donor, Project Advance provides scholarship opportunities for frontline ...
(Date:6/3/2020)... NEW YORK (PRWEB) , ... June 03, 2020 , ... ... annual Mobile in Clinical Trials conference to take place on September 21st, 2020. This ... digital technologies to reduce the barriers for patients and physicians to participate in clinical ...
Breaking Medicine Technology:
Cached News: